Mutsumi Kioka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mutsumi Kioka has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Kavita Batra
Office of Research, Department of Medical Education, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, USA
3 shared publications- Kavita Batra
Department of Medical Education and Office of Research, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, NV 89102, USA
2 shared publications Vidhani Goel
School of Public Health, University of Nevada, Las Vegas, Las Vegas, USA
2 shared publications- Aditi Singh
Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA
1 shared publication - Alfredo Iardino
Internal Medicine, Texas Tech University Health Science Center at the Permian Basin, Odessa, Texas, USA
1 shared publication Amrit Kooner
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV
1 shared publication
Latest Publications
- Open Access
- 25 August 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (8)
Probable Tigecycline‐Induced Acute Eosinophilic Pneumonia: A Case Report
A 25‐year‐old man developed acute hypoxaemic respiratory failure after 21 days of tigecycline therapy for osteomyelitis caused by multidrug‐resistant organisms. Chest computed tomography demonstrated bilateral consolidations, ground‐glass opacities, interlobular septal thickening, small bilateral pleural effusions and mediastinal lymphadenopathy. Bronchoalveolar lavage (BAL) revealed marked eosinophilia (99%–100%) despite minimal peripheral eosinophilia. Alternative causes, including infectious, parasitic, autoimmune and other potential aetiologies, were carefully evaluated. Based on the temporal relationship with tigecycline exposure, marked BAL eosinophilia, exclusion of alternative causes and the overall clinical presentation, probable tigecycline‐induced acute eosinophilic pneumonia (AEP) was diagnosed. Tigecycline was discontinued, cefiderocol was initiated for concomitant multidrug‐resistant Acinetobacter baumannii , and systemic corticosteroid therapy was administered, followed by progressive clinical and radiographic improvement. Although the clinical response followed multiple simultaneous interventions and therefore does not establish causality, the overall findings support tigecycline as the probable causative agent. To our knowledge, this is the first reported case of probable tigecycline‐associated AEP. This case highlights the importance of considering AEP in patients who develop unexplained respiratory deterioration during tigecycline therapy and underscores the diagnostic value of BAL, particularly in the absence of marked peripheral eosinophilia.
- 25 August 2026
- Published by Wiley in Respirology Case Reports
- Vol. 14 (8)
Open AccessProbable Tigecycline‐Induced Acute Eosinophilic Pneumonia: A Case Report
A 25‐year‐old man developed acute hypoxaemic respiratory failure after 21 days of tigecycline therapy for osteomyelitis caused by multidrug‐resistant organisms. Chest computed tomography demonstrated bilateral consolidations, ground‐glass opacities, interlobular septal thickening, small bilateral pleural effusions and mediastinal lymphadenopathy. Bronchoalveolar lavage (BAL) revealed marked eosinophilia (99%–100%) despite minimal peripheral eosinophilia. Alternative causes, including infectious, parasitic, autoimmune and other potential aetiologies, were carefully evaluated. Based on the temporal relationship with tigecycline exposure, marked BAL eosinophilia, exclusion of alternative causes and the overall clinical presentation, probable tigecycline‐induced acute eosinophilic pneumonia (AEP) was diagnosed. Tigecycline was discontinued, cefiderocol was initiated for concomitant multidrug‐resistant Acinetobacter baumannii , and systemic corticosteroid therapy was administered, followed by progressive clinical and radiographic improvement. Although the clinical response followed multiple simultaneous interventions and therefore does not establish causality, the overall findings support tigecycline as the probable causative agent. To our knowledge, this is the first reported case of probable tigecycline‐associated AEP. This case highlights the importance of considering AEP in patients who develop unexplained respiratory deterioration during tigecycline therapy and underscores the diagnostic value of BAL, particularly in the absence of marked peripheral eosinophilia.
- Open Access
- 2 August 2026
- Published by Springer Nature in Scientific Reports
Poor agreement between bioreactance and echocardiography during passive leg raising in patients with shock
- 2 August 2026
- Published by Springer Nature in Scientific Reports
Open AccessPoor agreement between bioreactance and echocardiography during passive leg raising in patients with shock
- Open Access
- 31 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (8)
Reversible complete atrioventricular block in immune checkpoint inhibitor–associated triple-M overlap syndrome: a case report
Background: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of advanced malignancies but are associated with rare and potentially life-threatening immune-related adverse events. Overlap syndromes involving myocarditis, myositis, and myasthenia gravis-referred to as Triple-M overlap syndrome-have been reported; however, reversible high-grade atrioventricular block remains uncommon. Case summary: A 74-year-old woman with advanced ovarian cancer treated with pembrolizumab presented with dyspnoea, myalgia, and right-sided ptosis 22 days after ICI therapy. Electrocardiography demonstrated ST-segment elevation in the anterior leads with markedly elevated high-sensitivity troponin. On the following day, persistent ST-segment elevation prompted evaluation for acute myocardial infarction, and coronary angiography revealed no obstructive coronary artery disease. The clinical course was complicated by sustained ventricular tachycardia followed by complete atrioventricular block requiring temporary transvenous pacing. Laboratory evaluation showed markedly elevated creatine kinase, and neurological findings were consistent with neuromuscular junction involvement. Immune-mediated Triple-M overlap syndrome was suspected, and high-dose corticosteroids and intravenous immunoglobulin were initiated. The patient demonstrated progressive clinical improvement, with resolution of arrhythmias and recovery of atrioventricular conduction. Discussion: This case highlights a rare presentation of ICI-associated Triple-M overlap syndrome complicated by reversible complete atrioventricular block. Immune-mediated conduction abnormalities may progress despite improving cardiac biomarkers, and early immunomodulatory therapy may enable reversibility of high-grade atrioventricular block.
- 31 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (8)
Open AccessReversible complete atrioventricular block in immune checkpoint inhibitor–associated triple-M overlap syndrome: a case report
Background: Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of advanced malignancies but are associated with rare and potentially life-threatening immune-related adverse events. Overlap syndromes involving myocarditis, myositis, and myasthenia gravis-referred to as Triple-M overlap syndrome-have been reported; however, reversible high-grade atrioventricular block remains uncommon. Case summary: A 74-year-old woman with advanced ovarian cancer treated with pembrolizumab presented with dyspnoea, myalgia, and right-sided ptosis 22 days after ICI therapy. Electrocardiography demonstrated ST-segment elevation in the anterior leads with markedly elevated high-sensitivity troponin. On the following day, persistent ST-segment elevation prompted evaluation for acute myocardial infarction, and coronary angiography revealed no obstructive coronary artery disease. The clinical course was complicated by sustained ventricular tachycardia followed by complete atrioventricular block requiring temporary transvenous pacing. Laboratory evaluation showed markedly elevated creatine kinase, and neurological findings were consistent with neuromuscular junction involvement. Immune-mediated Triple-M overlap syndrome was suspected, and high-dose corticosteroids and intravenous immunoglobulin were initiated. The patient demonstrated progressive clinical improvement, with resolution of arrhythmias and recovery of atrioventricular conduction. Discussion: This case highlights a rare presentation of ICI-associated Triple-M overlap syndrome complicated by reversible complete atrioventricular block. Immune-mediated conduction abnormalities may progress despite improving cardiac biomarkers, and early immunomodulatory therapy may enable reversibility of high-grade atrioventricular block.
- Open Access
- 4 March 2026
- Published by Elsevier in Preventive Medicine Reports
- Vol. 64, 103439
Critical care utilization associated with an electronic dance music festival in Las Vegas, Nevada: A retrospective cohort study of the electric daisy carnival
- 4 March 2026
- Published by Elsevier in Preventive Medicine Reports
- Vol. 64, 103439
Open AccessCritical care utilization associated with an electronic dance music festival in Las Vegas, Nevada: A retrospective cohort study of the electric daisy carnival
- Open Access
- 21 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (47) , e46228
Reversible junctional bigeminy in severe hyperkalemia: electrocardiographic and biochemical correlation: A case report
Rationale: Severe hyperkalemia is classically associated with peaked T waves, PR prolongation, and QRS widening. However, sustained bigeminal rhythms resulting from junctional escape are exceptionally rare. Detailed correlations between electrocardiographic (ECG) changes and serum potassium levels remain scarce in the literature. Patient concerns: A 54-year-old man with end-stage renal disease on maintenance hemodialysis presented with hypotension and bradycardia. Diagnoses: ECG revealed a striking bigeminal rhythm characterized by alternating supraventricular and junctional escape complexes, an uncommon arrhythmic manifestation of hyperkalemia. Laboratory testing showed a serum potassium level of 7.5 mmol/L. Interventions: The patient underwent emergent hemodialysis for rapid potassium removal and received standard supportive management for hyperkalemia. Outcomes: Following hemodialysis, serum potassium normalized to 3.7 mmol/L, and the bigeminal rhythm resolved completely, with restoration of normal sinus rhythm. Serial ECGs demonstrated dynamic and reversible conduction changes in parallel with biochemical correction. Lessons: This case highlights a rare but reversible presentation of junctional bigeminy secondary to hyperkalemia. Recognition of this distinctive ECG pattern – correlated with paired serum potassium values – can facilitate timely diagnosis and prevent unnecessary interventions.
- 21 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (47) , e46228
Open AccessReversible junctional bigeminy in severe hyperkalemia: electrocardiographic and biochemical correlation: A case report
Rationale: Severe hyperkalemia is classically associated with peaked T waves, PR prolongation, and QRS widening. However, sustained bigeminal rhythms resulting from junctional escape are exceptionally rare. Detailed correlations between electrocardiographic (ECG) changes and serum potassium levels remain scarce in the literature. Patient concerns: A 54-year-old man with end-stage renal disease on maintenance hemodialysis presented with hypotension and bradycardia. Diagnoses: ECG revealed a striking bigeminal rhythm characterized by alternating supraventricular and junctional escape complexes, an uncommon arrhythmic manifestation of hyperkalemia. Laboratory testing showed a serum potassium level of 7.5 mmol/L. Interventions: The patient underwent emergent hemodialysis for rapid potassium removal and received standard supportive management for hyperkalemia. Outcomes: Following hemodialysis, serum potassium normalized to 3.7 mmol/L, and the bigeminal rhythm resolved completely, with restoration of normal sinus rhythm. Serial ECGs demonstrated dynamic and reversible conduction changes in parallel with biochemical correction. Lessons: This case highlights a rare but reversible presentation of junctional bigeminy secondary to hyperkalemia. Recognition of this distinctive ECG pattern – correlated with paired serum potassium values – can facilitate timely diagnosis and prevent unnecessary interventions.
- Open Access
- 30 July 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-8
Anti-dipeptidyl-peptidase-like protein-6 antibody-associated encephalitis masquerading as weight loss and confusion: a case report
Anti-Dipeptidyl-peptidase-like protein-6 (DPPX) antibody-associated encephalitis is a rare autoimmune condition that affects the central and enteric nervous systems. It often presents with neuropsychiatric symptoms, cerebellar ataxia, and gastrointestinal dysmotility, though clinical manifestations can vary widely. We report the case of a 38-year-old woman with psychiatric symptoms who developed severe cognitive impairment, seizures, and a profound weight loss of 100 pounds over one year. Her symptoms initially led to multiple psychiatric diagnoses and treatments, delaying recognition of the underlying autoimmune process. Ultimately, cerebrospinal fluid analysis revealed high-titer anti-DPPX antibodies (1:1000). Despite aggressive immunotherapy—including corticosteroids, plasmapheresis, IVIG, and rituximab—the patient’s condition deteriorated, and she died under hospice care. This case expands the known clinical spectrum of anti-DPPX encephalitis by documenting the most extreme reported case of weight loss associated with the disease. The prodromal presentation with isolated weight loss underscores the diagnostic challenges when neuropsychiatric symptoms emerge late. Our case highlights the importance of maintaining clinical suspicion for autoimmune encephalitis in patients with unexplained weight loss and neurocognitive decline. Profound, unexplained weight loss may be an early and under-recognized manifestation of anti-DPPX encephalitis. Early recognition and immunotherapy are critical, but the potential for rapid progression and relapse demands heightened clinical vigilance and further research into optimal treatment strategies.
- 30 July 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-8
Open AccessAnti-dipeptidyl-peptidase-like protein-6 antibody-associated encephalitis masquerading as weight loss and confusion: a case report
Anti-Dipeptidyl-peptidase-like protein-6 (DPPX) antibody-associated encephalitis is a rare autoimmune condition that affects the central and enteric nervous systems. It often presents with neuropsychiatric symptoms, cerebellar ataxia, and gastrointestinal dysmotility, though clinical manifestations can vary widely. We report the case of a 38-year-old woman with psychiatric symptoms who developed severe cognitive impairment, seizures, and a profound weight loss of 100 pounds over one year. Her symptoms initially led to multiple psychiatric diagnoses and treatments, delaying recognition of the underlying autoimmune process. Ultimately, cerebrospinal fluid analysis revealed high-titer anti-DPPX antibodies (1:1000). Despite aggressive immunotherapy—including corticosteroids, plasmapheresis, IVIG, and rituximab—the patient’s condition deteriorated, and she died under hospice care. This case expands the known clinical spectrum of anti-DPPX encephalitis by documenting the most extreme reported case of weight loss associated with the disease. The prodromal presentation with isolated weight loss underscores the diagnostic challenges when neuropsychiatric symptoms emerge late. Our case highlights the importance of maintaining clinical suspicion for autoimmune encephalitis in patients with unexplained weight loss and neurocognitive decline. Profound, unexplained weight loss may be an early and under-recognized manifestation of anti-DPPX encephalitis. Early recognition and immunotherapy are critical, but the potential for rapid progression and relapse demands heightened clinical vigilance and further research into optimal treatment strategies.
- Open Access
- 23 July 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 362
Neurotoxic effects of scorpion envenomation, a video of nystagmus, dysmetria, and tongue fasciculations: a case report
Scorpion stings are common in rural areas worldwide, with most cases being benign. However, certain species, such as Centruroides in Southwestern USA, can cause severe neurotoxic envenomations. Neurotoxic symptoms, including nystagmus and ataxia, are well documented in pediatric cases but remain rare in adults. We present a rare case of neurotoxic scorpion envenomation in an adult. A 32-year-old Hispanic female with a history of anaphylaxis to bee venom presented to the emergency department (ED) following a scorpion sting. While sitting at home, she felt two stings on her posterior right thigh, identified and killed the scorpion, and went to the ED. On evaluation, the patient was alert and oriented (Glasgow Coma Scale score of 15). Her vital signs were stable, and laboratory results were unremarkable. The patient initially experienced localized pain at the sting site, followed by generalized heaviness, muscle twitching, dry mouth, tongue "fuzziness," and throat heaviness but no respiratory distress. Neurological examination revealed nystagmus, tongue fasciculations, and dysmetria, consistent with neurotoxic envenomation. She was treated with a tetanus-diphtheria-pertussis (Tdap) booster, normal saline, ondansetron, lorazepam, and Centruroides scorpion antivenom (ANASCORP®). Owing to her anaphylaxis history, she was closely monitored for hypersensitivity reactions. The patient had an uneventful recovery and was discharged after 2 days without neurological complications. Scorpion envenomations can lead to severe neurotoxic effects, even in adults, particularly with multiple stings or enhanced venom absorption. Early recognition of neurotoxic symptoms is crucial for prompt intervention with antivenom and supportive care, significantly improving patient outcomes. This case emphasizes the importance of considering neurotoxic envenomations in adult patients, even when pediatric cases are more common.
- 23 July 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 362
Open AccessNeurotoxic effects of scorpion envenomation, a video of nystagmus, dysmetria, and tongue fasciculations: a case report
Scorpion stings are common in rural areas worldwide, with most cases being benign. However, certain species, such as Centruroides in Southwestern USA, can cause severe neurotoxic envenomations. Neurotoxic symptoms, including nystagmus and ataxia, are well documented in pediatric cases but remain rare in adults. We present a rare case of neurotoxic scorpion envenomation in an adult. A 32-year-old Hispanic female with a history of anaphylaxis to bee venom presented to the emergency department (ED) following a scorpion sting. While sitting at home, she felt two stings on her posterior right thigh, identified and killed the scorpion, and went to the ED. On evaluation, the patient was alert and oriented (Glasgow Coma Scale score of 15). Her vital signs were stable, and laboratory results were unremarkable. The patient initially experienced localized pain at the sting site, followed by generalized heaviness, muscle twitching, dry mouth, tongue "fuzziness," and throat heaviness but no respiratory distress. Neurological examination revealed nystagmus, tongue fasciculations, and dysmetria, consistent with neurotoxic envenomation. She was treated with a tetanus-diphtheria-pertussis (Tdap) booster, normal saline, ondansetron, lorazepam, and Centruroides scorpion antivenom (ANASCORP®). Owing to her anaphylaxis history, she was closely monitored for hypersensitivity reactions. The patient had an uneventful recovery and was discharged after 2 days without neurological complications. Scorpion envenomations can lead to severe neurotoxic effects, even in adults, particularly with multiple stings or enhanced venom absorption. Early recognition of neurotoxic symptoms is crucial for prompt intervention with antivenom and supportive care, significantly improving patient outcomes. This case emphasizes the importance of considering neurotoxic envenomations in adult patients, even when pediatric cases are more common.
- Open Access
- 20 September 2024
- Published by Elsevier in Toxicology Reports
- Vol. 13, 101739
Rave gone wrong: MDMA- induced medical emergency at electrical daisy carnival. A case report
- 20 September 2024
- Published by Elsevier in Toxicology Reports
- Vol. 13, 101739
Open AccessRave gone wrong: MDMA- induced medical emergency at electrical daisy carnival. A case report
- Open Access
- 24 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (47) , e36196
A prospective study on the precision of height data from electronic medical records in tidal volume calculation for lung-protective ventilation
Lung-protective ventilation is now the norm for all patients, regardless of the presence of acute respiratory distress syndrome (ARDS), owing to the mortality associated with higher tidal volumes (TV). Clinicians calculate TV using recorded height from medical records and predicted body weight (PBW); however, the accuracy remains uncertain. Our study aimed to validate accurate TV settings for lung-protective ventilation by examining the correlation between the charted height and bedside measurements. In a single-center study, we compared PBW-based TV calculated from recorded height to PBW-based TV from measured height and identified factors causing height overestimation during charting. Our team measured patient height within 24 hours of admission using metal tape. TV calculated from recorded height (6–8 mL/kg PBW) was significantly larger (391.55 ± 65.98 to 522.07 ± 87.97) than measured height-based TV (162.62 ± 12.62 to 470.28 ± 89.64) (P < .01). In the height overestimated group, 57.7% were prescribed TV by healthcare provider, which was more than TV of 8 mL/kg of PBW, as determined by measured height. Negative predictors for height overestimation were male sex (OR: 0.45 [95% CI: 0.25–0.82]; P = .008) and presence of driver’s license information (OR: 0.45 [95% CI: 0.25–0.80]; P = .007), whereas Asian ethnicity was a positive predictor (OR: 4.34 [95% CI: 1.09–17.27]; P = .04). The height overestimation group had a higher in-patient mortality rate (38.5%) than the matched/underestimation group (20%) (P < .01). In stadiometer-limited hospitals, the PBW-based TV is overestimated using the recorded height instead of the measured height. In the group where heights were overestimated, over half of the patients received TV prescriptions from healthcare providers that surpassed the TV of calculated 8 mL/kg PBW based on their measured height. The risk factors for height overestimation include female sex, Asian ethnicity, and missing driver’s license data. Alternative height measurement methods should be explored to ensure precise ventilation settings and patient safety.
- 24 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (47) , e36196
Open AccessA prospective study on the precision of height data from electronic medical records in tidal volume calculation for lung-protective ventilation
Lung-protective ventilation is now the norm for all patients, regardless of the presence of acute respiratory distress syndrome (ARDS), owing to the mortality associated with higher tidal volumes (TV). Clinicians calculate TV using recorded height from medical records and predicted body weight (PBW); however, the accuracy remains uncertain. Our study aimed to validate accurate TV settings for lung-protective ventilation by examining the correlation between the charted height and bedside measurements. In a single-center study, we compared PBW-based TV calculated from recorded height to PBW-based TV from measured height and identified factors causing height overestimation during charting. Our team measured patient height within 24 hours of admission using metal tape. TV calculated from recorded height (6–8 mL/kg PBW) was significantly larger (391.55 ± 65.98 to 522.07 ± 87.97) than measured height-based TV (162.62 ± 12.62 to 470.28 ± 89.64) (P < .01). In the height overestimated group, 57.7% were prescribed TV by healthcare provider, which was more than TV of 8 mL/kg of PBW, as determined by measured height. Negative predictors for height overestimation were male sex (OR: 0.45 [95% CI: 0.25–0.82]; P = .008) and presence of driver’s license information (OR: 0.45 [95% CI: 0.25–0.80]; P = .007), whereas Asian ethnicity was a positive predictor (OR: 4.34 [95% CI: 1.09–17.27]; P = .04). The height overestimation group had a higher in-patient mortality rate (38.5%) than the matched/underestimation group (20%) (P < .01). In stadiometer-limited hospitals, the PBW-based TV is overestimated using the recorded height instead of the measured height. In the group where heights were overestimated, over half of the patients received TV prescriptions from healthcare providers that surpassed the TV of calculated 8 mL/kg PBW based on their measured height. The risk factors for height overestimation include female sex, Asian ethnicity, and missing driver’s license data. Alternative height measurement methods should be explored to ensure precise ventilation settings and patient safety.
- Open Access
- 6 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (40) , e35421
Comparing demographics, clinical characteristics, and hospital outcomes by vaccine uptake status: A single-institution cross-sectional study
Vaccination against Coronavirus disease 2019 (COVID-19) has been the cornerstone of reducing morbidity and mortality of this disease, as it has been shown to decrease the risk of viral transmission, severity of disease, hospitalization, and intubation. However, true understanding of its impact is skewed by heterogeneous vaccine administration due to lack of equitable access, vaccine hesitancy, and varying social determinants of health. Therefore, this study aims to identify groups that are less likely to be vaccinated and understand whether the resultant differences in vaccination rates affect morbidity and mortality in socially marginalized COVID-19 patients. A retrospective cohort analysis was performed on a randomized and stratified population of 939 COVID-19 patients from January 2021 to December 2021. Bivariate analysis and logistic regression were used to assess demographic and clinical characteristic trends in unvaccinated, partially vaccinated, and fully vaccinated groups. No one age (P = .21), gender (P = .9), race (P = .12), ethnicity (P = .09), or health insurance status (P = .13) group was more vaccinated than the other. Similarly, no subgroup was at increased odds of intubation (P = .08) or death. However, patients with all categories of comorbidities including cardiopulmonary disease (P = <.001, effect size .17), renal disease (P = <.001, effect size 0.138), metabolic disease (P = .04), and immunocompromised (P = .01) states were found to have significantly higher vaccination rates. Our study also shows that full vaccination protects against mortality and decreases the odds of intubation by 55% (adjusted odds ratio = 0.453, P value = .015) compared to no vaccination or partial vaccination. Findings from this study show an encouraging trend that sicker patients had higher rates of vaccination against COVID-19. This trend highlights the need for further identification of motivators that may be applied to vaccine-hesitant populations, which can help guide population-level policy, increase vaccination campaign yield, and reach for health equity.
- 6 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (40) , e35421
Open AccessComparing demographics, clinical characteristics, and hospital outcomes by vaccine uptake status: A single-institution cross-sectional study
Vaccination against Coronavirus disease 2019 (COVID-19) has been the cornerstone of reducing morbidity and mortality of this disease, as it has been shown to decrease the risk of viral transmission, severity of disease, hospitalization, and intubation. However, true understanding of its impact is skewed by heterogeneous vaccine administration due to lack of equitable access, vaccine hesitancy, and varying social determinants of health. Therefore, this study aims to identify groups that are less likely to be vaccinated and understand whether the resultant differences in vaccination rates affect morbidity and mortality in socially marginalized COVID-19 patients. A retrospective cohort analysis was performed on a randomized and stratified population of 939 COVID-19 patients from January 2021 to December 2021. Bivariate analysis and logistic regression were used to assess demographic and clinical characteristic trends in unvaccinated, partially vaccinated, and fully vaccinated groups. No one age (P = .21), gender (P = .9), race (P = .12), ethnicity (P = .09), or health insurance status (P = .13) group was more vaccinated than the other. Similarly, no subgroup was at increased odds of intubation (P = .08) or death. However, patients with all categories of comorbidities including cardiopulmonary disease (P = <.001, effect size .17), renal disease (P = <.001, effect size 0.138), metabolic disease (P = .04), and immunocompromised (P = .01) states were found to have significantly higher vaccination rates. Our study also shows that full vaccination protects against mortality and decreases the odds of intubation by 55% (adjusted odds ratio = 0.453, P value = .015) compared to no vaccination or partial vaccination. Findings from this study show an encouraging trend that sicker patients had higher rates of vaccination against COVID-19. This trend highlights the need for further identification of motivators that may be applied to vaccine-hesitant populations, which can help guide population-level policy, increase vaccination campaign yield, and reach for health equity.